Shrode, Rachel L.
Cady, Nicole
Jensen, Samantha N.
Borcherding, Nicholas
Mangalam, Ashutosh K.
Funding for this research was provided by:
Informatics Fellowship from the University of Iowa
Institutional Training Grant (T32AI007485)
Diversity Supplement Award to A.K.M. (1RO1AI137075)
P. Heppelmann and M. Wacek gift
National Institutes of health/NIAID (1RO1AI137075)
Veteran Affairs Merit Award (1I01CX002212)
University of Iowa Environmental Health Sciences Research Center, NIEHS/NIH (P30 ES005605)
Carver Trust Pilot Grant
Article History
Received: 18 July 2022
Accepted: 11 October 2022
First Online: 26 October 2022
Declarations
:
: A.K.M. is one of the inventors of a technology claiming the use of <i>Prevotella histicola</i> to treat autoimmune diseases. A.K.M. received royalties from Mayo Clinic (paid by Evelo Biosciences). However, no funds or products from the patent were used in the present study. All other authors declare no commercial or financial relationships that could be a potential conflict of interest.
: All procedures were done according to the Institutional Animal Care and Use Committee (IACUC) guidelines at the University of Iowa.